Target intelligence / Profile preview

Junctophilin-3 (JPH3)

Target
JPH3
Molecular classification
Junctional membrane complex protein, Scaffold protein, Other
01

Overview

Junctophilin-3 (JPH3) is a membrane-associated scaffold protein encoded by the JPH3 gene, primarily expressed in the brain, especially in neurons involved in motor coordination and memory[1][2][4]. It is a member of the junctophilin family, whose proteins form junctional membrane complexes linking the plasma membrane with the endoplasmic reticulum, facilitating precise calcium ion signaling essential for neuronal excitability and function[1][2][3][4][5]. The JPH3 gene contains a CAG/CTG trinucleotide repeat, and expansion of this repeat causes Huntington's disease-like 2 (HDL2), a rare neurodegenerative disorder clinically similar to Huntington’s disease[1][2][4]. In the context of cancer, JPH3 has been identified as a methylated tumor suppressor gene in colorectal and gastric cancers; loss or silencing of JPH3 promotes cancer cell proliferation and migration, while its re-expression induces apoptosis through mitochondrial pathways, partly by altering calcium homeostasis[5]. As of this writing, no approved drugs are known to target JPH3 directly, and it serves as a genetic and epigenetic biomarker for certain disorders[5].

Other names
Junctophilin 3JP3TNRC22JP-3CAGL237HDL2Junctophilin type 3Trinucleotide repeat-containing gene 22 proteintrinucleotide repeat containing 22junctophilin3
02

Biological functions

Formation of junctional membrane complex between plasma membrane and endoplasmic reticulumCalcium signaling in neuronsMaintenance of neuronal excitabilityStabilization of cellular architectureRegulation of mitochondrial apoptosis (in cancer context)
03

Disease associations

Neurodegenerative disease (Huntington's disease-like 2/HDL2)Cancer (tumor suppressor in colorectal and gastric cancer)Other (motor dysfunction)
04

Safety considerations

Neurodegeneration due to CAG/CTG repeat expansion (HDL2)Potential risks in therapies targeting neuronal calcium signaling
05

Biomarkers

Promoter methylation of JPH3 for digestive cancers (prognosis)CAG/CTG repeat expansion for Huntington's disease-like 2 diagnosis

Beyond the preview

Go deeper on Junctophilin-3 (JPH3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Junctophilin-3 (JPH3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call